HCW Biologics Inc.

HCWB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.91

+$0.04 (+2.14%)

At close: Sep 21, 2026, 4:00 PM ET

$1.97

+$0.06 (+3.07%)

Pre-market: Sep 22, 2026, 4:38 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.14%

(1D)

Rating

Updated: Aug 25, 2026

14.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $663.99K

1D Range

1.87 1.95

52W Range

1.50 29.28

Valuation (TTM)

PE -0.09

PB 0.09

EV/EBITDA -2.63

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $5

Cash Flow

FCF Yield -1827.8%

SBC Adj. FCF Yield -1830.9%

SBC Impact -0.2%

Margins

Gross Margin 95.9%

Operating Margin -91.6%

FCF Margin -180.6%

Growth (CAGR)

Revenue 3Y | 5Y 20.8% | 10.4%

Dil EPS 3Y | 5Y -33.2% | -51.3%

FCF 3Y | 5Y 32.6% | 10.9%

Returns

ROA -18.4%

ROE -142.2%

ROIC -39.3%

Financial Health

Net Debt

$5.82M

Current Ratio 0.06

Interest Coverage -17.08

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused...

Sector Healthcare

Industry Biotechnology

Employees 35

IPO Date Jul 19, 2021

Website www.hcwbiologics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+161.78%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞